Global Orphan Drugs Supply, Demand and Key Producers, 2023-2029

Description

The global Orphan Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Orphan drugs are medicines that are used to treat diseases that cannot be produced profitably without the assistance of the government because there are so few patients. Conditions that are treated are known as rare diseases.

This report studies the global Orphan Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Orphan Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Orphan Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Orphan Drugs total market, 2018-2029, (USD Million)
Global Orphan Drugs total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Orphan Drugs total market, key domestic companies and share, (USD Million)
Global Orphan Drugs revenue by player and market share 2018-2023, (USD Million)
Global Orphan Drugs total market by Type, CAGR, 2018-2029, (USD Million)
Global Orphan Drugs total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Orphan Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amber Specialty Pharmacy, Alexion Pharmaceuticals (Astra AB), Johnson & Johnson, Novartis, Celgene (Bristol-Myers Squibb), AbbVie, GSK, Roche and Sanofi, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Orphan Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Orphan Drugs Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Orphan Drugs Market, Segmentation by Type
    Biopharmaceutical
    Other

Global Orphan Drugs Market, Segmentation by Application
    Child
    Aldult

Companies Profiled:
    Amber Specialty Pharmacy
    Alexion Pharmaceuticals (Astra AB)
    Johnson & Johnson
    Novartis
    Celgene (Bristol-Myers Squibb)
    AbbVie
    GSK
    Roche
    Sanofi
    Pfizer
    Vertex
    Merck & Co.

Key Questions Answered
1. How big is the global Orphan Drugs market?
2. What is the demand of the global Orphan Drugs market?
3. What is the year over year growth of the global Orphan Drugs market?
4. What is the total value of the global Orphan Drugs market?
5. Who are the major players in the global Orphan Drugs market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Orphan Drugs Introduction
    1.2 World Orphan Drugs Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Orphan Drugs Total Market by Region (by Headquarter Location)
        1.3.1 World Orphan Drugs Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Orphan Drugs Market Size (2018-2029)
        1.3.3 China Orphan Drugs Market Size (2018-2029)
        1.3.4 Europe Orphan Drugs Market Size (2018-2029)
        1.3.5 Japan Orphan Drugs Market Size (2018-2029)
        1.3.6 South Korea Orphan Drugs Market Size (2018-2029)
        1.3.7 ASEAN Orphan Drugs Market Size (2018-2029)
        1.3.8 India Orphan Drugs Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Orphan Drugs Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Orphan Drugs Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Orphan Drugs Consumption Value (2018-2029)
    2.2 World Orphan Drugs Consumption Value by Region
        2.2.1 World Orphan Drugs Consumption Value by Region (2018-2023)
        2.2.2 World Orphan Drugs Consumption Value Forecast by Region (2024-2029)
    2.3 United States Orphan Drugs Consumption Value (2018-2029)
    2.4 China Orphan Drugs Consumption Value (2018-2029)
    2.5 Europe Orphan Drugs Consumption Value (2018-2029)
    2.6 Japan Orphan Drugs Consumption Value (2018-2029)
    2.7 South Korea Orphan Drugs Consumption Value (2018-2029)
    2.8 ASEAN Orphan Drugs Consumption Value (2018-2029)
    2.9 India Orphan Drugs Consumption Value (2018-2029)

3 World Orphan Drugs Companies Competitive Analysis
    3.1 World Orphan Drugs Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Orphan Drugs Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Orphan Drugs in 2022
        3.2.3 Global Concentration Ratios (CR8) for Orphan Drugs in 2022
    3.3 Orphan Drugs Company Evaluation Quadrant
    3.4 Orphan Drugs Market: Overall Company Footprint Analysis
        3.4.1 Orphan Drugs Market: Region Footprint
        3.4.2 Orphan Drugs Market: Company Product Type Footprint
        3.4.3 Orphan Drugs Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Orphan Drugs Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Orphan Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Orphan Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Orphan Drugs Consumption Value Comparison
        4.2.1 United States VS China: Orphan Drugs Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Orphan Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Orphan Drugs Companies and Market Share, 2018-2023
        4.3.1 United States Based Orphan Drugs Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Orphan Drugs Revenue, (2018-2023)
    4.4 China Based Companies Orphan Drugs Revenue and Market Share, 2018-2023
        4.4.1 China Based Orphan Drugs Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Orphan Drugs Revenue, (2018-2023)
    4.5 Rest of World Based Orphan Drugs Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Orphan Drugs Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Orphan Drugs Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Orphan Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Biopharmaceutical
        5.2.2 Other
    5.3 Market Segment by Type
        5.3.1 World Orphan Drugs Market Size by Type (2018-2023)
        5.3.2 World Orphan Drugs Market Size by Type (2024-2029)
        5.3.3 World Orphan Drugs Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Orphan Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Child
        6.2.2 Aldult
    6.3 Market Segment by Application
        6.3.1 World Orphan Drugs Market Size by Application (2018-2023)
        6.3.2 World Orphan Drugs Market Size by Application (2024-2029)
        6.3.3 World Orphan Drugs Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Amber Specialty Pharmacy
        7.1.1 Amber Specialty Pharmacy Details
        7.1.2 Amber Specialty Pharmacy Major Business
        7.1.3 Amber Specialty Pharmacy Orphan Drugs Product and Services
        7.1.4 Amber Specialty Pharmacy Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Amber Specialty Pharmacy Recent Developments/Updates
        7.1.6 Amber Specialty Pharmacy Competitive Strengths & Weaknesses
    7.2 Alexion Pharmaceuticals (Astra AB)
        7.2.1 Alexion Pharmaceuticals (Astra AB) Details
        7.2.2 Alexion Pharmaceuticals (Astra AB) Major Business
        7.2.3 Alexion Pharmaceuticals (Astra AB) Orphan Drugs Product and Services
        7.2.4 Alexion Pharmaceuticals (Astra AB) Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Alexion Pharmaceuticals (Astra AB) Recent Developments/Updates
        7.2.6 Alexion Pharmaceuticals (Astra AB) Competitive Strengths & Weaknesses
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Details
        7.3.2 Johnson & Johnson Major Business
        7.3.3 Johnson & Johnson Orphan Drugs Product and Services
        7.3.4 Johnson & Johnson Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Johnson & Johnson Recent Developments/Updates
        7.3.6 Johnson & Johnson Competitive Strengths & Weaknesses
    7.4 Novartis
        7.4.1 Novartis Details
        7.4.2 Novartis Major Business
        7.4.3 Novartis Orphan Drugs Product and Services
        7.4.4 Novartis Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Novartis Recent Developments/Updates
        7.4.6 Novartis Competitive Strengths & Weaknesses
    7.5 Celgene (Bristol-Myers Squibb)
        7.5.1 Celgene (Bristol-Myers Squibb) Details
        7.5.2 Celgene (Bristol-Myers Squibb) Major Business
        7.5.3 Celgene (Bristol-Myers Squibb) Orphan Drugs Product and Services
        7.5.4 Celgene (Bristol-Myers Squibb) Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Celgene (Bristol-Myers Squibb) Recent Developments/Updates
        7.5.6 Celgene (Bristol-Myers Squibb) Competitive Strengths & Weaknesses
    7.6 AbbVie
        7.6.1 AbbVie Details
        7.6.2 AbbVie Major Business
        7.6.3 AbbVie Orphan Drugs Product and Services
        7.6.4 AbbVie Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 AbbVie Recent Developments/Updates
        7.6.6 AbbVie Competitive Strengths & Weaknesses
    7.7 GSK
        7.7.1 GSK Details
        7.7.2 GSK Major Business
        7.7.3 GSK Orphan Drugs Product and Services
        7.7.4 GSK Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 GSK Recent Developments/Updates
        7.7.6 GSK Competitive Strengths & Weaknesses
    7.8 Roche
        7.8.1 Roche Details
        7.8.2 Roche Major Business
        7.8.3 Roche Orphan Drugs Product and Services
        7.8.4 Roche Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Roche Recent Developments/Updates
        7.8.6 Roche Competitive Strengths & Weaknesses
    7.9 Sanofi
        7.9.1 Sanofi Details
        7.9.2 Sanofi Major Business
        7.9.3 Sanofi Orphan Drugs Product and Services
        7.9.4 Sanofi Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Sanofi Recent Developments/Updates
        7.9.6 Sanofi Competitive Strengths & Weaknesses
    7.10 Pfizer
        7.10.1 Pfizer Details
        7.10.2 Pfizer Major Business
        7.10.3 Pfizer Orphan Drugs Product and Services
        7.10.4 Pfizer Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Pfizer Recent Developments/Updates
        7.10.6 Pfizer Competitive Strengths & Weaknesses
    7.11 Vertex
        7.11.1 Vertex Details
        7.11.2 Vertex Major Business
        7.11.3 Vertex Orphan Drugs Product and Services
        7.11.4 Vertex Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Vertex Recent Developments/Updates
        7.11.6 Vertex Competitive Strengths & Weaknesses
    7.12 Merck & Co.
        7.12.1 Merck & Co. Details
        7.12.2 Merck & Co. Major Business
        7.12.3 Merck & Co. Orphan Drugs Product and Services
        7.12.4 Merck & Co. Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Merck & Co. Recent Developments/Updates
        7.12.6 Merck & Co. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Orphan Drugs Industry Chain
    8.2 Orphan Drugs Upstream Analysis
    8.3 Orphan Drugs Midstream Analysis
    8.4 Orphan Drugs Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Orphan Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Orphan Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Orphan Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Orphan Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Orphan Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Orphan Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Orphan Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Orphan Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Orphan Drugs Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Orphan Drugs Players in 2022
    Table 12. World Orphan Drugs Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Orphan Drugs Company Evaluation Quadrant
    Table 14. Head Office of Key Orphan Drugs Player
    Table 15. Orphan Drugs Market: Company Product Type Footprint
    Table 16. Orphan Drugs Market: Company Product Application Footprint
    Table 17. Orphan Drugs Mergers & Acquisitions Activity
    Table 18. United States VS China Orphan Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Orphan Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Orphan Drugs Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Orphan Drugs Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Orphan Drugs Revenue Market Share (2018-2023)
    Table 23. China Based Orphan Drugs Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Orphan Drugs Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Orphan Drugs Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Orphan Drugs Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Orphan Drugs Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Orphan Drugs Revenue Market Share (2018-2023)
    Table 29. World Orphan Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Orphan Drugs Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Orphan Drugs Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Orphan Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Orphan Drugs Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Orphan Drugs Market Size by Application (2024-2029) & (USD Million)
    Table 35. Amber Specialty Pharmacy Basic Information, Area Served and Competitors
    Table 36. Amber Specialty Pharmacy Major Business
    Table 37. Amber Specialty Pharmacy Orphan Drugs Product and Services
    Table 38. Amber Specialty Pharmacy Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Amber Specialty Pharmacy Recent Developments/Updates
    Table 40. Amber Specialty Pharmacy Competitive Strengths & Weaknesses
    Table 41. Alexion Pharmaceuticals (Astra AB) Basic Information, Area Served and Competitors
    Table 42. Alexion Pharmaceuticals (Astra AB) Major Business
    Table 43. Alexion Pharmaceuticals (Astra AB) Orphan Drugs Product and Services
    Table 44. Alexion Pharmaceuticals (Astra AB) Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Alexion Pharmaceuticals (Astra AB) Recent Developments/Updates
    Table 46. Alexion Pharmaceuticals (Astra AB) Competitive Strengths & Weaknesses
    Table 47. Johnson & Johnson Basic Information, Area Served and Competitors
    Table 48. Johnson & Johnson Major Business
    Table 49. Johnson & Johnson Orphan Drugs Product and Services
    Table 50. Johnson & Johnson Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Johnson & Johnson Recent Developments/Updates
    Table 52. Johnson & Johnson Competitive Strengths & Weaknesses
    Table 53. Novartis Basic Information, Area Served and Competitors
    Table 54. Novartis Major Business
    Table 55. Novartis Orphan Drugs Product and Services
    Table 56. Novartis Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Novartis Recent Developments/Updates
    Table 58. Novartis Competitive Strengths & Weaknesses
    Table 59. Celgene (Bristol-Myers Squibb) Basic Information, Area Served and Competitors
    Table 60. Celgene (Bristol-Myers Squibb) Major Business
    Table 61. Celgene (Bristol-Myers Squibb) Orphan Drugs Product and Services
    Table 62. Celgene (Bristol-Myers Squibb) Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Celgene (Bristol-Myers Squibb) Recent Developments/Updates
    Table 64. Celgene (Bristol-Myers Squibb) Competitive Strengths & Weaknesses
    Table 65. AbbVie Basic Information, Area Served and Competitors
    Table 66. AbbVie Major Business
    Table 67. AbbVie Orphan Drugs Product and Services
    Table 68. AbbVie Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. AbbVie Recent Developments/Updates
    Table 70. AbbVie Competitive Strengths & Weaknesses
    Table 71. GSK Basic Information, Area Served and Competitors
    Table 72. GSK Major Business
    Table 73. GSK Orphan Drugs Product and Services
    Table 74. GSK Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. GSK Recent Developments/Updates
    Table 76. GSK Competitive Strengths & Weaknesses
    Table 77. Roche Basic Information, Area Served and Competitors
    Table 78. Roche Major Business
    Table 79. Roche Orphan Drugs Product and Services
    Table 80. Roche Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Roche Recent Developments/Updates
    Table 82. Roche Competitive Strengths & Weaknesses
    Table 83. Sanofi Basic Information, Area Served and Competitors
    Table 84. Sanofi Major Business
    Table 85. Sanofi Orphan Drugs Product and Services
    Table 86. Sanofi Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Sanofi Recent Developments/Updates
    Table 88. Sanofi Competitive Strengths & Weaknesses
    Table 89. Pfizer Basic Information, Area Served and Competitors
    Table 90. Pfizer Major Business
    Table 91. Pfizer Orphan Drugs Product and Services
    Table 92. Pfizer Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Pfizer Recent Developments/Updates
    Table 94. Pfizer Competitive Strengths & Weaknesses
    Table 95. Vertex Basic Information, Area Served and Competitors
    Table 96. Vertex Major Business
    Table 97. Vertex Orphan Drugs Product and Services
    Table 98. Vertex Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Vertex Recent Developments/Updates
    Table 100. Merck & Co. Basic Information, Area Served and Competitors
    Table 101. Merck & Co. Major Business
    Table 102. Merck & Co. Orphan Drugs Product and Services
    Table 103. Merck & Co. Orphan Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 104. Global Key Players of Orphan Drugs Upstream (Raw Materials)
    Table 105. Orphan Drugs Typical Customers
List of Figure
    Figure 1. Orphan Drugs Picture
    Figure 2. World Orphan Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Orphan Drugs Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Orphan Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Orphan Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Orphan Drugs Revenue (2018-2029) & (USD Million)
    Figure 13. Orphan Drugs Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Orphan Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Orphan Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Orphan Drugs by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Orphan Drugs Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Orphan Drugs Markets in 2022
    Figure 27. United States VS China: Orphan Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Orphan Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Orphan Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Orphan Drugs Market Size Market Share by Type in 2022
    Figure 31. Biopharmaceutical
    Figure 32. Other
    Figure 33. World Orphan Drugs Market Size Market Share by Type (2018-2029)
    Figure 34. World Orphan Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Orphan Drugs Market Size Market Share by Application in 2022
    Figure 36. Child
    Figure 37. Aldult
    Figure 38. Orphan Drugs Industrial Chain
    Figure 39. Methodology
    Figure 40. Research Process and Data Source

Companies Mentioned

Amber Specialty Pharmacy
Alexion Pharmaceuticals (Astra AB)
Johnson & Johnson
Novartis
Celgene (Bristol-Myers Squibb)
AbbVie
GSK
Roche
Sanofi
Pfizer
Vertex
Merck & Co.